These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2508416)
21. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188 [TBL] [Abstract][Full Text] [Related]
22. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Besinger UA; Toyka KV; Hömberg M; Heininger K; Hohlfeld R; Fateh-Moghadam A Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226 [TBL] [Abstract][Full Text] [Related]
23. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis. Pták J Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750 [TBL] [Abstract][Full Text] [Related]
24. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051 [TBL] [Abstract][Full Text] [Related]
25. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase]. Maruyama N; Shigemoto K Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813 [TBL] [Abstract][Full Text] [Related]
26. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)]. Sanadze AG; Sidnev DV; Karganov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492 [TBL] [Abstract][Full Text] [Related]
33. [Modulation of experimental myasthenia gravis by IVIg]. Berrih-Aknin S; Aissaoui A; Yamamoto M; Kaveri SV Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S25-9. PubMed ID: 10896985 [TBL] [Abstract][Full Text] [Related]
34. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586 [TBL] [Abstract][Full Text] [Related]
35. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis. Lefvert AK Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836 [No Abstract] [Full Text] [Related]
36. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis. Heilbronn E; Lefvert AK; Stålberg E Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985 [TBL] [Abstract][Full Text] [Related]
37. Immunopathology of myasthenia gravis. Drachman DB Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751 [No Abstract] [Full Text] [Related]
38. The role of acetylcholine receptor antibodies in myasthenia gravis. Appel SH; Elias SB; Chauvin P Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014 [TBL] [Abstract][Full Text] [Related]
39. The effects of myasthenic immunoglobulins on neuromuscular transmission and thymus histology in mice. Dalkara T; Onur R; Ruacan SA; Topaktaş S Neurology; 1983 Oct; 33(10):1356-9. PubMed ID: 6310440 [TBL] [Abstract][Full Text] [Related]